RNA-seq Identifies FOS as a Potential Therapeutic Target Activating Neural Stem Cells via miR-21/SOX2 Pathway in Hypertensive Intracerebral Hemorrhage
RNA-seq (gene expression) · human · 53 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 53 samples: 28 × ICH vs 25 × shGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE335924_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1479820 and SRA study SRP710764. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 53 samples.
How we read this: 2 replicated groups read from 53 sample titles; they account for 53 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9823271 ICH1 ICH
- GSM9823272 ICH2 ICH
- GSM9823273 ICH3 ICH
- GSM9823274 ICH4 ICH
- GSM9823275 ICH5 ICH
- GSM9823276 ICH6 ICH
- GSM9823277 ICH7 ICH
- GSM9823278 ICH8 ICH
- GSM9823279 ICH9 ICH
- GSM9823280 ICH10 ICH
- GSM9823281 ICH11 ICH
- GSM9823282 ICH12 ICH
- GSM9823283 ICH13 ICH
- GSM9823284 ICH14 ICH
- GSM9823285 ICH15 ICH
- GSM9823286 ICH16 ICH
- GSM9823287 ICH17 ICH
- GSM9823288 ICH18 ICH
- GSM9823289 ICH19 ICH
- GSM9823290 ICH20 ICH
- GSM9823291 ICH21 ICH
- GSM9823292 ICH22 ICH
- GSM9823293 ICH23 ICH
- GSM9823294 ICH24 ICH
- GSM9823295 ICH25 ICH
- GSM9823296 ICH26 ICH
- GSM9823297 ICH27 ICH
- GSM9823298 ICH28 ICH
- GSM9823299 sh1 sh
- GSM9823300 sh2 sh
- GSM9823301 sh3 sh
- GSM9823302 sh4 sh
- GSM9823303 sh5 sh
- GSM9823304 sh6 sh
- GSM9823305 sh7 sh
- GSM9823306 sh8 sh
- GSM9823307 sh9 sh
- GSM9823308 sh10 sh
- GSM9823309 sh11 sh
- GSM9823310 sh12 sh
+ 13 more — browse all 53 samples with per-sample file links →
- GSE278409 Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer [RNA_SEQ_FOSL1 and JUN KO] 10 samples shares fos, identifies
- GSE289045 Disrupting SOX2 Self-Association and Condensates to Overcome Chemotherapeutic Drug Resistance in Lung Squamous Cell Carcinoma [RNA-Seq] 6 samples shares sox2, therapeutic
- GSE314519 Disrupting SOX2 Self-Association and Condensates to Overcome Chemotherapeutic Drug Resistance in Lung Squamous Cell Carcinoma [RNA-Seq, 2] 4 samples shares sox2, therapeutic
- GSE295702 Human Nail Single-Cell Landscape Identifies KRT19+ NSCs and SOX2/SOX9-WNT Regulated Differentiation 3 samples shares sox2, identifies
- GSE262009 Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple negative breast cancer. 54 samples shares sox2, therapeutic
- GSE289048 Disrupting SOX2 Self-Association and Condensates to Overcome Chemotherapeutic Drug Resistance in Lung Squamous Cell Carcinoma 14 samples shares sox2, therapeutic
- GSE308945 The Histone Methyltransferase KMT2D is a Critical Mediator of Lineage Plasticity and Therapeutic Response in Castration Resistant Prostate Cancer [FOSL1 ChIP-Seq] 8 samples shares fos, therapeutic
- GSE314516 Disrupting SOX2 Self-Association and Condensates to Overcome Chemotherapeutic Drug Resistance in Lung Squamous Cell Carcinoma [Cut & Run, 2] 2 samples shares sox2, therapeutic
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.